FBLG Financial Statements

Balance sheet, income statement, cash flow, and dividends for Fibrobiologics Inc (FBLG).


$69.32M Market Cap.

As of 03/31/2025 5:00 PM ET (MRY) • Disclaimer

FBLG Market Cap. (MRY)


FBLG Shares Outstanding (MRY)


FBLG Assets (MRY)


Total Assets

$16.45M

Total Liabilities

$13.71M

Total Investments

$0

FBLG Income (MRY)


Revenue

$0

Net Income

-$11.16M

Operating Expense

$13.74M

FBLG Cash Flow (MRY)


CF Operations

-$11.90M

CF Investing

-$184.00K

CF Financing

$16.91M

FBLG Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

-

-

0%

-

FBLG Balance Sheet (MRY)


Metric

2024

2023

Total Assets

$16,445,000 (39.12%)

$11,821,000

Assets Current

$14,228,000 (54.40%)

$9,215,000

Assets Non-Current

$2,217,000 (-14.93%)

$2,606,000

Goodwill & Intangible Assets

$0 (0%)

$0

Shareholders Equity

$2,735,000 (118.28%)

$1,253,000

Property Plant & Equipment Net

$2,217,000 (-14.93%)

$2,606,000

Cash & Equivalents

$13,985,000 (52.62%)

$9,163,000

Accumulated Other Comprehensive Income

$0 (0%)

$0

Deferred Revenue

$0 (0%)

$0

Total Investments

$0 (0%)

$0

Investments Current

$0 (0%)

$0

Investments Non-Current

$0 (0%)

$0

Inventory

$0 (0%)

$0

Trade & Non-Trade Receivables

$0 (0%)

$0

Trade & Non-Trade Payables

$2,697,000 (86.77%)

$1,444,000

Accumulated Retained Earnings (Deficit)

-$35,518,000 (-45.82%)

-$24,357,000

Tax Assets

$0 (0%)

$0

Tax Liabilities

$0 (0%)

$0

Total Debt

$10,553,000 (458.95%)

$1,888,000

Debt Current

$9,569,000 (1802.39%)

$503,000

Debt Non-Current

$984,000 (-28.95%)

$1,385,000

Total Liabilities

$13,710,000 (29.73%)

$10,568,000

Liabilities Current

$12,726,000 (38.58%)

$9,183,000

Liabilities Non-Current

$984,000 (-28.95%)

$1,385,000

FBLG Income Statement (MRY)


Metric

2024

2023

Revenues

$0 (0%)

$0

Cost of Revenue

$0 (0%)

$0

Selling General & Administrative Expense

$9,233,000 (41.59%)

$6,521,000

Research & Development Expense

$4,504,000 (90.20%)

$2,368,000

Operating Expenses

$13,737,000 (54.54%)

$8,889,000

Interest Expense

$20,000 (-86.39%)

$147,000

Income Tax Expense

$0 (0%)

$0

Net Loss Income from Discontinued Operations

$0 (0%)

$0

Consolidated Income

-$11,161,000 (32.30%)

-$16,485,000

Net Income to Non-Controlling Interests

$0 (0%)

$0

Net Income

-$11,161,000 (32.30%)

-$16,485,000

Preferred Dividends Income Statement Impact

$0 (0%)

$2,573,000

Net Income Common Stock

-$11,161,000 (41.44%)

-$19,058,000

Weighted Average Shares

$32,875,075 (16.45%)

$28,230,842

Weighted Average Shares Diluted

$32,875,075 (16.45%)

$28,230,842

Earning Before Interest & Taxes (EBIT)

-$11,141,000 (31.81%)

-$16,338,000

Gross Profit

$0 (0%)

$0

Operating Income

-$13,737,000 (-54.54%)

-$8,889,000

FBLG Cash Flow Statement (MRY)


Metric

2024

2023

Net Cash Flow from Investing

-$184,000 (62.83%)

-$495,000

Net Cash Flow from Financing

$16,907,000 (22.58%)

$13,793,000

Net Cash Flow from Operations

-$11,901,000 (-85.92%)

-$6,401,000

Net Cash Flow / Change in Cash & Cash Equivalents

$4,822,000 (-30.09%)

$6,897,000

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0

Capital Expenditure

-$184,000 (62.83%)

-$495,000

Issuance (Repayment) of Debt Securities

$9,400,000 (3033.33%)

$300,000

Issuance (Purchase) of Equity Shares

$7,507,000 (0%)

$0

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0

Share Based Compensation

$2,219,000 (25.72%)

$1,765,000

Depreciation Amortization & Accretion

$573,000 (31.12%)

$437,000

FBLG Financial Metrics (MRY)


Metric

2024

2023

Gross Margin

-

-

Profit Margin

-

-

EBITDA Margin

-

-

Return on Average Equity (ROAE)

5738.30% (312.95%)

1389.60%

Return on Average Assets (ROAA)

-94.50% (58.73%)

-229.00%

Return on Sales (ROS)

-

-

Return on Invested Capital (ROIC)

275.40% (-86.28%)

2007.10%

Dividend Yield

0%

-

Price to Earnings Ratio (P/E)

-5.88

-

Price to Sales Ratio (P/S)

-

-

Price to Book Ratio (P/B)

25.34

-

Debt to Equity Ratio (D/E)

5.01 (-40.56%)

8.43

Earnings Per Share (EPS)

-0.34 (50.00%)

-0.68

Sales Per Share (SPS)

0 (0%)

0

Free Cash Flow Per Share (FCFPS)

-0.37 (-50.82%)

-0.24

Book Value Per Share (BVPS)

0.08 (88.64%)

0.04

Tangible Assets Book Value Per Share (TABVPS)

0.5 (19.33%)

0.42

Enterprise Value Over EBIT (EV/EBIT)

-6

-

Enterprise Value Over EBITDA (EV/EBITDA)

-5.97

-

Asset Turnover

0 (0%)

0

Current Ratio

1.12 (11.47%)

1

Dividends

$0 (0%)

$0

Free Cash Flow (FCF)

-$12,085,000 (-75.25%)

-$6,896,000

Enterprise Value (EV)

$63,053,250

-

Earnings Before Tax (EBT)

-$11,161,000 (32.30%)

-$16,485,000

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$10,568,000 (33.54%)

-$15,901,000

Invested Capital

$287,000 (106.19%)

-$4,637,000

Working Capital

$1,502,000 (4593.75%)

$32,000

Tangible Asset Value

$16,445,000 (39.12%)

$11,821,000

Market Capitalization

$69,318,250

-

Average Equity

-$194,500 (85.82%)

-$1,371,500

Average Assets

$11,806,250 (41.86%)

$8,322,500

Invested Capital Average

-$4,044,750 (-396.90%)

-$814,000

Shares

34,659,125 (22.77%)

28,230,842